Author

Craig D Logsdon

Retired Professor of Cancer Biology, UT MD Anderson Cancer Center - Cited by 21,738 - Pancreatic Cancer/Pancreatitis

Biography

Dr. Logsdon is interested in understanding pancreatic diseases. He has made several original contributions to pancreatology including the first descriptions of primary acinar cultures; the first demonstration of direct effects of EGF, FGF, and TGFb, the discovery that human acinar cells lack CCK receptors, the first direct evidence of NFkB induced pancreatitis, the first studies on ER stress in pancreatitis, and the first direct proof that intracellular trypsin can initiate pancreatitis.
Title
Cited by
Year
The immune system in cancer metastasis: friend or foe?
LME Janssen, EE Ramsay, CD Logsdon, WW OverwijkJournal for immunotherapy of cancer 5 (1), 1-14, 2017201
219
2017
Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
G Mahmoodi Chalbatani, H Dana, E Gharagouzloo, S Grijalvo, R Eritja, ...International journal of nanomedicine, 3111-3128, 2019201
187
2019
Lipocalin-2 promotes pancreatic ductal adenocarcinoma by regulating inflammation in the tumor microenvironment
SB Gomez-Chou, AK Swidnicka-Siergiejko, N Badi, M Chavez-Tomar, ...Cancer research 77 (10), 2647-2660, 2017201
107
2017
Galectin-3 mediates tumor cell–stroma interactions by activating pancreatic stellate cells to produce cytokines via integrin signaling
W Zhao, JA Ajani, G Sushovan, N Ochi, R Hwang, M Hafley, RL Johnson, ...Gastroenterology 154 (5), 1524-1537. e6, 2018201
88
2018
The significance of Ras activity in pancreatic cancer initiation
CD Logsdon, W LuInternational journal of biological sciences 12 (3), 338, 2016201
71
2016
Oncogenic KRAS reduces expression of FGF21 in acinar cells to promote pancreatic tumorigenesis in mice on a high-fat diet
Y Luo, Y Yang, M Liu, D Wang, F Wang, Y Bi, J Ji, S Li, Y Liu, R Chen, ...Gastroenterology 157 (5), 1413-1428. e11, 2019201
54
2019
Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53
AK Swidnicka-Siergiejko, SB Gomez-Chou, Z Cruz-Monserrate, D Deng, ...Oncogene 36 (22), 3149-3158, 2017201
50
2017
The interface of pancreatic cancer with diabetes, obesity, and inflammation: research gaps and opportunities: summary of a National Institute of Diabetes and Digestive and …
JL Abbruzzese, DK Andersen, CAK Borrebaeck, ST Chari, E Costello, ...Pancreas 47 (5), 516, 2018201
48
2018
TM4SF1 regulates pancreatic cancer migration and invasion in vitro and in vivo
J Cao, J Yang, V Ramachandran, T Arumugam, D Deng, Z Li, L Xu, ...Cellular Physiology and Biochemistry 39 (2), 740-750, 2016201
41
2016
The lineage determining factor GRHL2 collaborates with FOXA1 to establish a targetable pathway in endocrine therapy-resistant breast cancer
KJ Cocce, JS Jasper, TK Desautels, L Everett, S Wardell, T Westerling, ...Cell reports 29 (4), 889-903. e10, 2019201
37
2019
DIRAS3 (ARHI) blocks RAS/MAPK signaling by binding directly to RAS and disrupting RAS clusters
MN Sutton, Z Lu, YC Li, Y Zhou, T Huang, AS Reger, AM Hurwitz, ...Cell reports 29 (11), 3448-3459. e6, 2019201
35
2019
Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma
L Zhou, H Husted, T Moore, M Lu, D Deng, Y Liu, V Ramachandran, ...Science translational medicine 10 (464), eaat3487, 2018201
33
2018
TM4SF1 promotes gemcitabine resistance of pancreatic cancer in vitro and in vivo
J Cao, J Yang, V Ramachandran, T Arumugam, D Deng, Z Li, L Xu, ...PloS one 10 (12), e0144969, 2015201
31
2015
Transgenic expression of PRSS1R122H sensitizes mice to pancreatitis
H Huang, AK Swidnicka-Siergiejko, J Daniluk, S Gaiser, Y Yao, L Peng, ...Gastroenterology 158 (4), 1072-1082. e7, 2020202
31
2020
RAGE maintains high levels of NFκB and oncogenic Kras activity in pancreatic cancer
N Azizan, MA Suter, Y Liu, CD LogsdonBiochemical and biophysical research communications 493 (1), 592-597, 2017201
28
2017
Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer
K Singh, M Pruski, R Bland, M Younes, S Guha, N Thosani, A Maitra, ...Laboratory Investigation 101 (2), 177-192, 2021202
24
2021
Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS
D Wang, Y Bi, L Hu, Y Luo, J Ji, AZ Mao, CD Logsdon, E Li, ...Cell Communication and Signaling 17 (1), 1-9, 2019201
22
2019
Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics
CD Logsdon, T Arumugam, V RamachandranAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 309 (5 …, 2015201
21
2015
A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women
L Chen, Z Duan, L Tinker, H Sangi-Haghpeykar, H Strickler, GYF Ho, ...Cancer epidemiology 42, 1-123, 2016201
15
2016
Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer
X Song, H Akasaka, H Wang, R Abbasgholizadeh, JH Shin, F Zang, ...Journal of Biological Chemistry 295 (8), 2348-2358, 2020202
12
2020

Referred From: https://scholar.google.com/citations?user=fpPuDYMAAAAJ&hl=en

Cited by
Citations 21738
h-index 82
i10-index 209
Recommended Journals
Open Access Journals